CN121057584A - 设计的细菌组合物用于感染治疗的用途 - Google Patents

设计的细菌组合物用于感染治疗的用途

Info

Publication number
CN121057584A
CN121057584A CN202480023173.7A CN202480023173A CN121057584A CN 121057584 A CN121057584 A CN 121057584A CN 202480023173 A CN202480023173 A CN 202480023173A CN 121057584 A CN121057584 A CN 121057584A
Authority
CN
China
Prior art keywords
seq
rdna
clostridium
sequence shown
sequences shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480023173.7A
Other languages
English (en)
Chinese (zh)
Inventor
E·哈尔沃森
N·恩尼斯
J·伍斯特
E·奥布里恩
K·巴拉索
N·鲍舍曼
M·乌里克
M·马约尔
L·贾
K·巴尔丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seres Health Inc
Original Assignee
Seres Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seres Health Inc filed Critical Seres Health Inc
Publication of CN121057584A publication Critical patent/CN121057584A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202480023173.7A 2023-01-30 2024-01-31 设计的细菌组合物用于感染治疗的用途 Pending CN121057584A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363482293P 2023-01-30 2023-01-30
US63/482,293 2023-01-30
PCT/US2024/013624 WO2024163529A2 (fr) 2023-01-30 2024-01-31 Utilisation de compositions bactériennes synthétiques pour un traitement infectieux

Publications (1)

Publication Number Publication Date
CN121057584A true CN121057584A (zh) 2025-12-02

Family

ID=92147571

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480023173.7A Pending CN121057584A (zh) 2023-01-30 2024-01-31 设计的细菌组合物用于感染治疗的用途

Country Status (6)

Country Link
EP (1) EP4687930A2 (fr)
JP (1) JP2026503724A (fr)
CN (1) CN121057584A (fr)
AU (1) AU2024215611A1 (fr)
MX (1) MX2025008862A (fr)
WO (1) WO2024163529A2 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
JP7846613B2 (ja) * 2019-08-09 2026-04-15 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 病原菌を抑制するための組成物及び方法
CN115279382A (zh) * 2019-10-18 2022-11-01 芬奇治疗控股有限责任公司 用于向受试者递送细菌代谢物的组合物和方法
WO2022115646A1 (fr) * 2020-11-25 2022-06-02 Seres Therapeutics, Inc. Compositions bactériennes conçues pour traiter une maladie du greffon contre l'hôte
WO2022204357A1 (fr) * 2021-03-24 2022-09-29 Board Of Regents, The University Of Texas System Procédés et compositions pour le traitement de la fièvre neutropénique induite par le traitement du cancer et/ou de la maladie du greffon contre l'hôte

Also Published As

Publication number Publication date
JP2026503724A (ja) 2026-01-29
EP4687930A2 (fr) 2026-02-11
MX2025008862A (es) 2026-01-07
WO2024163529A9 (fr) 2025-01-02
AU2024215611A1 (en) 2025-08-14
WO2024163529A3 (fr) 2025-05-15
WO2024163529A2 (fr) 2024-08-08

Similar Documents

Publication Publication Date Title
Roy et al. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
US11896628B2 (en) Methods and compositions for the treatment of C. difficile
KR101353692B1 (ko) 프로바이오틱 및 프리바이오틱 성분 및 무기 염을 락토페린과 함께 포함하는 조성물
JP2019104742A (ja) 病原性細菌生育の抑制のための組成物および方法
US20240000859A1 (en) Designed bacterial compositions for treating graft-versus-host-disease
WO2016086209A1 (fr) Compositions probiotiques et prébiotiques et procédés pour les utiliser pour le traitement de troubles gastro-intestinaux
JP2019527213A (ja) グリカン組成物および使用方法
CN107708704A (zh) 微生物组调节剂和其相关用途
CN104955466A (zh) 协同细菌组合物和其制造方法和用途
MX2012007735A (es) Composiciones y metodo para el tratamiento y profilaxis de enfermedad inflamatoria intestinal.
ITMI961329A1 (it) Composizioni per diete enteriche e metodi d'uso delle stesse
US20200215129A1 (en) Methods and compositions for treating gastrointestinal and inflammatory disorders
CN112118852A (zh) 用于治疗炎症性肠病的组合物和方法
CN115175575A (zh) 设计的细菌组合物及其用途
US20240226191A1 (en) Compositions and methods for treating disease
Yang et al. Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection
O'May et al. Health claims associated with probiotics
CN121057584A (zh) 设计的细菌组合物用于感染治疗的用途
WO2021067167A1 (fr) Traitement de clostridioides difficile
RU2799556C2 (ru) Композиции и способы лечения воспалительных заболеваний кишечника
US20240358777A1 (en) Compositions comprising bacillus amyloliquefaciens for preventing and treating ulcerative colitis
HK1161691A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination